A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction

Clinical Journal of Pain

Volumn 27, Issue 8, 2011, Pages 668-676

  Ostenfeld, Thor ^a   Price, Jeffrey ^a   Albanese, Massimo ^b   Bullman, Jonathan ^a   Guillard, Fiona ^a   Meyer, Ingo ^c   Leeson, Rachel ^d   Costantin, Cristina ^e   Ziviani, Luigi ^e   Nocini, Pier Francesco ^b   Milleri, Stefano ^e  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF VERONA   (Italy)

^c Momentum Pharma Services   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Centro Ricerche Cliniche di Verona   (Italy)

Author keywords

analgesia; GW842166; postoperative pain; selective CB2 agonist

Indexed keywords

ANTIBIOTIC AGENT; COCODAMOL; GW 842166; IBUPROFEN; PLACEBO;

ABSCESS; ADULT; ANALGESIA; ARTICLE; BLEEDING; BONE MARROW RESCUE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DYSPEPSIA; DYSPHAGIA; EVALUATION; FEAR OF PAIN QUESTIONNAIRE; FEMALE; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MOLAR TOOTH; NAUSEA; NAUSEA AND VOMITING; PAIN ASSESSMENT; PATIENT GLOBAL EVALUATION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SORE THROAT; STOMACH DISCOMFORT; SUBMANDIBULAR ABSCESS; SYNCOPE; THIRD MOLAR TOOTH EXTRACTION; TOOTH DISEASE; TOOTH EXTRACTION; TREATMENT DURATION; VERBAL RATING SCALE; VISUAL ANALOG SCALE;

EID: 80052718419     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318219799a     Document Type: Article

References (44)

1. Choong KC, Su X, Urban MO. Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation. Neurosci Lett. 2007;414:105-109. (Pubitemid 46273983)
2. Clayton N, Marshall FH, Bountra C, et al. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain. 2002;96:253-260. (Pubitemid 34327871)
3. Ibrahim MM, Deng H, Zvonok A, et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA. 2003;100:10529-10533. (Pubitemid 37071912)
4. Malan TP Jr, Ibrahim MM, Deng H, et al. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain. 2001;93: 239-245. (Pubitemid 32763181)
5. Quartilho A, Mata HP, Ibrahim MM, et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology. 2003;99:955-960. (Pubitemid 37186088)
6. Whiteside GT, Lee GP, Valenzano KJ. The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists. Curr Med Chem. 2007;14:917-936. (Pubitemid 46863619)
7. Jhaveri MD, Sagar DR, Elmes SJ, et al. Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. Mol Neurobiol. 2007;36:26-35. (Pubitemid 351360358)
8. Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol. 2008;153:319-334.
9. Thakur GA, Tichkule R, Bajaj S, et al. Latest advances in cannabinoid receptor agonists. Expert Opin Ther Pat. 2009;19:1647-1673.
10. Anand P, Whiteside G, Fowler CJ, et al. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev. 2009;60:255-266.
11. Giblin GM, O'Shaughnessy CT, Naylor A, et al. Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)-methyl] -4-(trifluoromethyl)-5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain. J Med Chem. 2007;50:2597-2600. (Pubitemid 46896065)
12. Ovadia H, Wohlman A, Mechoulam R, et al. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology. 1995;34:175-180.
13. Ross RA, Brockie HC, Stevenson LA, et al. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol. 1999;126:665-672. (Pubitemid 29087845)
14. Forbes JA, Butterworth GA, Burchfield WH, et al. Evaluation of ketorolac, aspirin, and an acetaminophen-codeine combination in postoperative oral surgery pain. Pharmacotherapy. 1990;10:77S-93S.
15. Chang DJ, Desjardins PJ, Chen E, et al. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial. Clin Ther. 2002;24:490-503. (Pubitemid 34492872)
16. Desjardins PJ, Shu VS, Recker DP, et al. A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. Anesthesiology. 2002;97:565-573. (Pubitemid 34977314)
17. Doyle G, Jayawardena S, Ashraf E, et al. Efficacy and tolerability of nonprescription ibuprofen versus celecoxib for dental pain. J Clin Pharmacol. 2002;42:912-919. (Pubitemid 34803855)
18. Varner J, Lomax M, Blum D, et al. A randomized, controlled, dose-ranging study investigating single doses of GW406381, naproxen sodium, or placebo in patients with acute pain after third molar tooth extraction. Clin J Pain. 2009;25:577-583.
19. McNeil DW, Rainwater AJ III. Development of the Fear of Pain Questionnaire-III. J Behav Med. 1998;21:389-410.
20. Dionne RA, Cooper SA. Evaluation of preoperative ibuprofen for postoperative pain after removal of third molars. Oral Surg Oral Med Oral Pathol. 1978;45:851-856. (Pubitemid 8371589)
21. Urquhart E. Analgesic agents and strategies in the dental pain model. J Dent. 1994;22:336-341.
22. Malmstrom K, Fricke JR, Kotey P, et al. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo-and activecomparator-controlled, parallel-group, single-dose study using the dental impaction pain model. Clin Ther. 2002;24:1549-1560. (Pubitemid 35351841)
23. Malmstrom K, Sapre A, Couglin H, et al. Etoricoxib in acute pain associated with dental surgery: a randomized, doubleblind, placebo-and active comparator-controlled dose-ranging study. Clin Ther. 2004;26:667-679. (Pubitemid 38736957)
24. Morrison BW, Christensen S, Yuan W, et al. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in postdental surgery pain: a randomized, controlled trial. Clin Ther. 1999;21:943-953. (Pubitemid 29326155)
25. Chiu WK, Cheung LK. Efficacy of preoperative oral rofecoxib in pain control for third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:e47-e53. (Pubitemid 40719343)
26. Esteller-Martinez V, Paredes-Garcia J, Valmaseda-Castellon E, et al. Analgesic efficacy of diclofenac sodium versus ibuprofen following surgical extraction of impacted lower third molars. Med Oral Pathol Oral Circ Bucal. 2004;9: 448-453.
27. Joshi A, Parara E, Macfarlane TV. A double-blind randomised controlled clinical trial of the effect of preoperative ibuprofen, diclofenac, paracetamol with codeine and placebo tablets for relief of postoperative pain after removal of impacted third molars. Br J Oral Maxillofac Surg. 2004; 42:299-306. (Pubitemid 38842811)
28. Morse Z, Tump A, Kevelham E. Ibuprofen as a pre-emptive analgesic is as effective as rofecoxib for mandibular third molar surgery. Odontology. 2006;94:59-63. (Pubitemid 44463455)
29. Tong SE, Daniles SE, Montano T, et al. SCIO-469, a novel P38A MAPK inhibitor, provides efficacy in acute post-surgical dental pain. Clin Pharm Ther. 2004;75:P3.
30. Gustorff B, Hoerauf KH, Lierz P, et al. Comparison of different quantitative sensory testing methods during remifentanil infusion in volunteers. Br J Anaesth. 2003;91: 203-208. (Pubitemid 36950193)
31. Pavlakovic G, Tigges J, Crozier TA. Effect of buspirone on thermal sensory and pain thresholds in human volunteers. BMC Clin Pharmacol. 2009;9:12.
32. van Wijk A, Lindeboom J. The effect of a separate consultation on anxiety levels before third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:303-307.
33. van Wijk AJ, Hoogstraten J. Experience with dental pain and fear of dental pain. J Dent Res. 2005;947-950. (Pubitemid 43827805)
34. Anand U, Otto WR, Sanchez-Herrera D, et al. Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain. 2008; 138:667-680.
35. Desjardins PJ, Traylor L, Hubbard RC. Analgesic efficacy of preoperative parecoxib sodium in an orthopedic pain model. J Am Podiatr Med Assoc. 2004;94:305-314. (Pubitemid 38721468)
36. Desjardins PJ, Black PM, Daniels S, et al. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin. 2004;20:1523-1537. (Pubitemid 39457541)
37. Gimbel JS, Brugger A, Zhao W, et al. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther. 2001;23:228-241. (Pubitemid 32231113)
38. CB2-Selective Program: Cannabinor [Pharmos Corporation website]. Available at http://www.pharmoscorp.com/development/cannabinor.html [accessed 31st January 2011].
39. Pain Drugs Discovery [Glenmark website]. Available at http://www.glenmarkpharma.com/UITemplate/HtmlContainer.aspx? res=P-GLN-GDY-BNCE-AHRC [Accessed January 31, 2011].
40. Raft D, Gregg J, Ghia J, et al. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response. Clin Pharmacol Ther. 1977;21:26-33. (Pubitemid 8024156)
41. Buggy DJ, Toogood L, Maric S, et al. Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain. 2003;106:169-172. (Pubitemid 37329627)
42. Beaulieu P. Effects of nabilone, a synthetic cannabinoid, on postoperative pain. Can J Anaesth. 2006;53:769-775. (Pubitemid 44420062)
43. Jain AK, Ryan JR, McMahon FG, et al. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol. 1981;21:320S-326S.
44. Holdcroft A, Maze M, Dore C, et al. A multicenter doseescalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management. Anesthesiology. 2006;104:1040-1046.